Lee, J.U.; Shin, W.; Son, J.Y.; Yoo, K.-Y.; Heo, Y.-S.
Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases. Int. J. Mol. Sci. 2017, 18, 228.
https://doi.org/10.3390/ijms18010228
AMA Style
Lee JU, Shin W, Son JY, Yoo K-Y, Heo Y-S.
Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases. International Journal of Molecular Sciences. 2017; 18(1):228.
https://doi.org/10.3390/ijms18010228
Chicago/Turabian Style
Lee, Jee Un, Woori Shin, Ji Young Son, Ki-Young Yoo, and Yong-Seok Heo.
2017. "Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases" International Journal of Molecular Sciences 18, no. 1: 228.
https://doi.org/10.3390/ijms18010228
APA Style
Lee, J. U., Shin, W., Son, J. Y., Yoo, K.-Y., & Heo, Y.-S.
(2017). Molecular Basis for the Neutralization of Tumor Necrosis Factor α by Certolizumab Pegol in the Treatment of Inflammatory Autoimmune Diseases. International Journal of Molecular Sciences, 18(1), 228.
https://doi.org/10.3390/ijms18010228